- Equity Portfolio Manager
Formats
Corporate Sustainability
Investment Solutions
Our approach to sustainability
France, Intermediary
ChangeThe views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
I have published my views on Brazil more than once over the past year (most recently in my November 2021 blog post), but the environment there has changed markedly through the first few months of this year, with COVID-related risks seemingly on the wane and the Russia/Ukraine conflict having driven up commodity prices — so I thought now would be an opportune time to share a fresh perspective on South America’s most populous country.
To wit, some of my colleagues and I just returned from a productive business trip to the bustling metropolis of Sao Paulo, where we visited retail, financial, health care, and education companies. Based on our conversations with firm executives and others, we found the corporates’ mood to be quite positive overall. And why not? Business trends have been on the upswing, mask mandates were recently lifted, soybean prices are sky-high as of this writing, and (for better or worse) the city’s notoriously brutal traffic is back again.
My main takeaway from this trip and my team’s latest research: At the country level, I think Brazil is a “buy” right now and perhaps through the rest of 2022 as well (though time will tell.) At the company level, as always, there are of course both risks and opportunities for investors to be mindful of.
My investment case for Brazil
At present, my bullish outlook for Brazil is predicated on several key factors, including:
- What’s different vs 20 years ago: The Brazilian Congress has matured into a formidable check on the Executive branch, the Central Bank of Brazil is now independent, and Brazilian corporates as a group have stronger balance sheets than in the past.
- The interest-rate cycle: Encouragingly, the Central Bank of Brazil has been hawkish thus far in its efforts to rein in inflation. It has raised interest rates from 2% to 12% and, other than China, may be the first emerging market central bank to cut rates again (in 2023).
- A strengthening currency: The Brazilian real (BRL) has strengthened on the back of rising interest rates and may continue to do so going forward amid favorable terms of trade — higher soybean, oil, and iron ore prices — and positive currency carry trade.1
- Lower election risk: Brazil’s 2022 general election will decide the country’s next president on October 2. While it’s not a risk-free contest, Brazilian markets have already priced in a sizable risk premium and, I think, can fare well regardless of the outcome.
- Attractive valuation: Brazil’s equity market is trading at what appears to be an attractive discount to both Brazilian bonds and broader emerging market equities (Figure 1). Some higher-quality domestic cyclicals look particularly attractive to me from a valuation standpoint.
Figure 1
1Positive carry is an investment strategy that involves investing borrowed money and then earning a profit on the difference between the return and the interest owed. Investors commonly use positive carry in currency markets.
Expert
Related insights
Showing
of
Insights Posts
Health care investing: new opportunities in a challenging environment
Continue reading
Event replay
2024-03-31
URL References
Related Insights
Stay up to date with the latest market insights and our point of view.
Read next
Showing
of
Insights Posts
Health care investing: new opportunities in a challenging environment
In this insightful session moderated by Wellington CEO Jean Hynes, our global industry experts assess the current environment for health care investing and outline why advances in biopharmaceutical innovation and the evolving landscape in health care services should favor active managers with deep subsector expertise.
Event replay
2024-03-31
The allocator’s perspective: three key decisions on EM equities
How can investors best access opportunities within an improving outlook for emerging market equities? Natasha Brook-Walters, co-head of iStrat, shares three key decision points for allocators.
Article
2024-03-31
China in 2022 - Uncorrelated but far from broken
Macro Strategist Santiago Millan highlights a trend of falling correlations between China’s economy and asset prices versus their global counterparts.
Continue reading
Quick Take
2022-08-31
Tying ESG to alpha — in practice
In a climate-driven capital cycle, companies that prioritise the environment and formulate clear climate strategies can become market leaders.
Continue reading
Event replay
2022-10-31
Five investment essentials for a post-pandemic world
As the world “gets back to business” in 2022, a cautiously optimistic outlook seems warranted. For investors, it may be a year to think thematically.
Continue reading
Article
2022-11-30
Should China equity be a stand-alone allocation?
As China’s role on the world stage looms larger, should investors separate the country from the rest of their emerging markets (EM) equity allocation? Three of our multi-asset strategists provide their research-based take, along with some practical considerations.
Continue reading
Quick Take
2022-05-31
“Buy now, pay later” is at a turning point
For Portfolio Manager Matt Lipton, recent developments have strengthened his conviction that up-and-coming “buy now, pay later” companies cannot and should not be ignored by banks and other legacy players in the global payments space.
Continue reading
Quick Take
2021-11-30
EM inflation has arrived, but will it stick around?
Emerging markets inflation has been top of mind for many investors lately. Macro Strategist Gillian Edgeworth, Equity Portfolio Manager Jamie Rice, and Fixed Income Portfolio Manager Michael Henry consider the outlook going forward and potential market implications.
Continue reading
Article
2022-07-29
EM equity looks more attractive than it’s been in a decade
Equity Portfolio Manager Jamie Rice describes his bullish stance on emerging markets (EM) equities and looks at China’s burgeoning A-share market.
Continue reading
Article
2021-07-30
Game on: Fintech disruptors vs old-school banks
Fintech companies are forcing traditional banks to up their game and rethink their business strategy, including the products they offer. Global Industry Analyst Matt Ross takes a closer look.
Continue reading
Article
2021-08-31
ESG research playbook: Health care
Wellington has established frameworks — what we call “research playbooks” — for evaluating companies within each sector based on key ESG criteria. ESG Analyst Lindsay Blitstein looks at the health care sector here.
Continue reading
Quick Take
2022-04-30
URL References
Related Insights